(Q43618436)

25 November 2017

title

Study of effectiveness of bezafibrate in the treatment of chronic hepatitis C. (English)

1 reference

25 November 2017

Kurihara T

1

1 reference

25 November 2017

Niimi A

2

1 reference

25 November 2017

Maeda A

3

1 reference

25 November 2017

Shigemoto M

4

1 reference

25 November 2017

Yamashita K

5

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

The American Journal of Gastroenterology

25 November 2017

published in

1 reference

25 November 2017

volume

96

1 reference

25 November 2017

issue

5

1 reference

25 November 2017

page(s)

1659-1660

1 reference

Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03831.X

Crossref

reference URL

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03831.X

Crossref

reference URL

Bezafibrate in the treatment of primary biliary cirrhosis: comparison with ursodeoxycholic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03831.X

Crossref

reference URL

10.1111/J.1572-0241.2001.03831.X

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference